The ECPC and the importance of patient input in clinical research
We know that MRD is relevant, what next?
The CRUK Facilitator programme: from the lab to the clinic
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
The adoption of biosimilars in Oxford: a case study